The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors
- PMID: 21349414
- DOI: 10.1016/j.ecl.2010.12.001
The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors
Abstract
Chromogranin A, although it exhibits limitations, is currently the most useful general tumor biomarker available for use in the diagnosis and management of gastroenteropancreatic neuroendocrine tumors (NETs). The value of the chromogranin A lies in its universal cosecretion by the majority of neuroendocrine cells that persists after malignant transformation. Clinicians aware of the physiologic role of chromogranin A and its secretion in a variety of non-NET-related pathologic conditions can use this protein as a moderately effective tumor biomarker in the management of GEP-NETs.
Copyright © 2011 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
